Hematopoietic Stem Cell Transplantation

Ten-second videos of white blood cell motion in the skin’s microvasculature considerably improved the ability to predict whether blood cancer would relapse after hematopoietic stem cell transplantation, according to study results.

Healio spoke with Heather Stefanski, MD, PhD, for a three-part video series about trends in the field of bone marrow transplantation.

Brenda M. Sandmaier, MD, has been named the 2022-2023 president of American Society for Transplantation and Cellular Therapy.

Ira Braunschweig, MD, has been appointed as section chief of transplant and cell therapy at Rutgers Cancer Institute of New Jersey.

SALT LAKE CITY — Ibrutinib appeared safe and effective for children with previously untreated or relapsed/refractory chronic graft-versus-host disease, according to study results.

SALT LAKE CITY — Socioeconomic disadvantage among hematopoietic stem cell transplant donors appeared associated with poorer outcomes among transplant recipients, according to study results.

SALT LAKE CITY — Academic center outreach to community practices considerably increased stem cell transplant referrals for patients with multiple myeloma, according to study results.

SALT LAKE CITY — Prevalence of organ dysfunction appeared low among pediatric patients who underwent hematopoietic stem cell transplantation for sickle cell disease, according to retrospective study results.

SALT LAKE CITY — Early azithromycin use did not affect hematologic relapse among pediatric hematopoietic stem cell transplant recipients, according to study results.

SALT LAKE CITY — Patients with relapsed or refractory large B-cell lymphoma who failed chimeric antigen receptor T-cell therapy achieved durable responses with allogeneic hematopoietic stem cell transplantation, according to study results.